Reaction of 2‐[(2‐aminoethyl)amino]ethanol with pyridine‐2‐carbaldehyde and complexation of the products with CuII and CdII along with docking studies

The reaction between 2‐[2‐(aminoethyl)amino]ethanol and pyridine‐2‐carbaldehyde in a 1:2 molar ratio affords a mixture containing 2‐({2‐[(pyridin‐2‐ylmethylidene)amino]ethyl}amino)ethanol (PMAE) and 2‐[2‐(pyridin‐2‐yl)oxazolidin‐3‐yl]‐N‐(pyridin‐2‐ylmethylidene)ethanamine (POPME). Treatment of this mixture with copper(II) chloride or cadmium(II) chloride gave trichlorido[(2‐hydroxyethyl)({2‐[(pyridin‐2‐ylmethylidene)amino]ethyl})azanium]copper(II) monohydrate, [Cu(C₁₀H₁₆N₃O)Cl₃]·H₂O or [Cu(HPMAE)Cl₃]·H₂O, 1 , and dichlorido{2‐[2‐(pyridin‐2‐yl)oxazolidin‐3‐yl]‐N‐(pyridin‐2‐ylmethylidene)ethanamine}cadmium(II), [CdCl₂(C₁₆H₁₈N₄O)] or [CdCl₂(POPME)], 2 , which were characterized by elemental analysis, FT–IR, Raman and ¹H NMR spectroscopy and single‐crystal X‐ray diffraction. PMAE is potentially a tetradentate N₃O‐donor ligand but coordinates to copper here as an N₂ donor. In the structure of 1 , the geometry around the Cu atom is distorted square pyramidal. In 2 , the Cd atom has a distorted octahedral geometry. In addition to the hydrogen bonds, there are π–π stacking interactions between the pyridine rings in the crystal packing of 1 and 2 . The ability of PMAE, POPME and 1 to interact with ten selected biomolecules (BRAF kinase, CatB, DNA gyrase, HDAC7, rHA, RNR, TrxR, TS, Top II and B‐DNA) was investigated by docking studies and compared with doxorubicin.     

Almotriptan,an antimigraine agent,and its malate salt

The crystal structures of almotriptan {systematic name: N,N‐dimethyl‐2‐[5‐(pyrrolidin‐1‐ylsulfonylmethyl)‐1H‐indol‐3‐yl]ethanamine}, C₁₇H₂₅N₃O₂S, and almotriptan malate {systematic name: N,N‐dimethyl‐2‐[5‐(pyrrolidin‐1‐ylsulfonylmethyl)‐1H‐indol‐3‐yl]ethanaminium malate, C₁₇H₂₆N₃O₂S⁺·C₄H₅O₅⁻, a novel selective serotonin 1B/D agonist, have been determined in order to gain further insight into the structure–activity relationships of triptans. The two structures differ in the orientation of their sulfonylpyrrolidine side chains. A comparison with other triptans reveals that molecules of almotriptan, sumatriptan, zolmitriptan and rizatriptan can adopt two principal conformations. N—H...N, N—H...O and O—H...O hydrogen bonds are responsible for the molecular packing.     

(2S,3S)‐2,6‐Dimethylheptane‐1,3‐diol,the oxygenated side chain of 22(S)‐hydroxycholestrol,and its synthetic precursor (R)‐4‐benzyl‐3‐[(2R,3S)‐3‐hydroxy‐2,6‐dimethylheptanoyl]‐1,3‐oxazolidin‐2‐one

(2S,3S)‐2,6‐Dimethylheptane‐1,3‐diol, C₉H₂₀O₂, (I), was synthesized from the ketone (R)‐4‐benzyl‐3‐[(2R,3S)‐3‐hydroxy‐2,6‐dimethylheptanoyl]‐1,3‐oxazolidin‐2‐one, C₁₉H₂₇NO₄, (II), containing C atoms of known chirality. In both structures, strong hydrogen bonds between the hydroxy groups form tape motifs. The contribution from weaker C—H...O hydrogen bonds is much more evident in the structure of (II), which furthermore contains an example of a direct short Osp³...Csp² contact that represents a usually unrecognized type of intermolecular interaction.     

Salt forms of the pharmaceutical amide dihydrocarbamazepine

Carbamazepine (CBZ) is well known as a model active pharmaceutical ingredient used in the study of polymorphism and the generation and comparison of cocrystal forms. The pharmaceutical amide dihydrocarbamazepine (DCBZ) is a less well known material and is largely of interest here as a structural congener of CBZ. Reaction of DCBZ with strong acids results in protonation of the amide functionality at the O atom and gives the salt forms dihydrocarbamazepine hydrochloride {systematic name: [(10,11‐dihydro‐5H‐dibenzo[b,f]azepin‐5‐yl)(hydroxy)methylidene]azanium chloride, C₁₅H₁₅N₂O⁺·Cl⁻}, dihydrocarbamazepine hydrochloride monohydrate {systematic name: [(10,11‐dihydro‐5H‐dibenzo[b,f]azepin‐5‐yl)(hydroxy)methylidene]azanium chloride monohydrate, C₁₅H₁₅N₂O⁺·Cl⁻·H₂O} and dihydrocarbamazepine hydrobromide monohydrate {systematic name: [(10,11‐dihydro‐5H‐dibenzo[b,f]azepin‐5‐yl)(hydroxy)methylidene]azanium bromide monohydrate, C₁₅H₁₅N₂O⁺·Br⁻·H₂O}. The anhydrous hydrochloride has a structure with two crystallographically independent ion pairs (Z′ = 2), wherein both cations adopt syn conformations, whilst the two hydrated species are mutually isostructural and have cations with anti conformations. Compared to neutral dihydrocarbamazepine structures, protonation of the amide group is shown to cause changes to both the molecular (C=O bond lengthening and C—N bond shortening) and the supramolecular structures. The amide‐to‐amide and dimeric hydrogen‐bonding motifs seen for neutral polymorphs and cocrystalline species are replaced here by one‐dimensional polymeric constructs with no direct amide‐to‐amide bonds. The structures are also compared with, and shown to be closely related to, those of the salt forms of the structurally similar pharmaceutical carbamazepine.     

Halide salts of antimigraine agents eletriptan and naratriptan

Molecules of eletriptan hydrobromide monohydrate (systematic name: (1S,2R)‐1‐methyl‐2‐{5‐[2‐(phenylsulfonyl)ethyl]‐1H‐indol‐3‐ylmethyl}pyrrolidinium bromide monohydrate), C₂₂H₂₇N₂O₂S⁺·Br⁻·H₂O, (I), and naratriptan hydrochloride (systematic name: 1‐methyl‐4‐{5‐[2‐(methylsulfamoyl)ethyl]‐1H‐indol‐3‐yl}piperidinium chloride), C₁₇H₂₆N₃O₂S⁺·Cl⁻, (II), adopt conformations similar to other triptans. The C‐2 and C‐5 substituents of the indole ring, both of which are in a region of conformational flexibility, are found to be oriented on either side of the indole ring plane in (I), whilst they are on the same side in (II). The N atom in the C‐2 side chain is protonated in both structures and is involved in the hydrogen‐bonding networks. In (I), the water molecules create helical hydrogen‐bonded chains along the c axis. In (II), the hydrogen bonding of the chloride ions results in macrocyclic R₄²(20) and R₄²(24) ring motifs that form sheets in the bc plane. This structural analysis provides an insight into the molecular structure–activity relationships within this class of compound, which is of use for drug development.     

Synthesis,crystal structures,antiproliferative activities and reverse docking studies of eight novel Schiff bases derived from benzil

Eight novel Schiff bases derived from benzil dihydrazone ( BDH ) or benzil monohydrazone ( BMH ) and four fused‐ring carbonyl compounds (3‐formylindole, FI ; 3‐acetylindole, AI ; 3‐formyl‐1‐methylindole, MFI ; 1‐formylnaphthalene, FN ) were synthesized and characterized by elemental analysis, ESI–QTOF–MS, ¹H and ¹³C NMR spectroscopy, as well as single‐crystal X‐ray diffraction. They are (1Z,2Z)‐1,2‐bis{(E)‐[(1H‐indol‐3‐yl)methylidene]hydrazinylidene}‐1,2‐diphenylethane ( BDHFI ), C₃₂H₂₄N₆, (1Z,2Z)‐1,2‐bis{(E)‐[1‐(1H‐indol‐3‐yl)ethylidene]hydrazinylidene}‐1,2‐diphenylethane ( BDHAI ), C₃₄H₂₈N₆, (1Z,2Z)‐1,2‐bis{(E)‐[(1‐methyl‐1H‐indol‐3‐yl)methylidene]hydrazinylidene}‐1,2‐diphenylethane ( BMHMFI ) acetonitrile hemisolvate, C₃₄H₂₈N₆·0.5CH₃CN, (1Z,2Z)‐1,2‐bis{(E)‐[(naphthalen‐1‐yl)methylidene]hydrazinylidene}‐1,2‐diphenylethane ( BDHFN ), C₃₆H₂₆N₄, (Z)‐2‐{(E)‐[(1H‐indol‐3‐yl)methylidene]hydrazinylidene}‐1,2‐diphenylethanone ( BMHFI ), C₂₃H₁₇N₃O, (Z)‐2‐{(E)‐[1‐(1H‐indol‐3‐yl)ethylidene]hydrazinylidene}‐1,2‐diphenylethanone ( BMHAI ), C₂₄H₁₉N₃O, (Z)‐2‐{(E)‐[(1‐methyl‐1H‐indol‐3‐yl)methylidene]hydrazinylidene}‐1,2‐diphenylethanone ( BMHMFI ), C₂₄H₁₉N₃O, and (Z)‐2‐{(E)‐[(naphthalen‐1‐yl)methylidene]hydrazinylidene}‐1,2‐diphenylethanone ( BMHFN ) C₂₅H₁₈N₂O. Moreover, the in vitro cytotoxicity of the eight title compounds was evaluated against two tumour cell lines (A549 human lung cancer and 4T₁ mouse breast cancer) and two normal cell lines (MRC‐5 normal lung cells and NIH 3T3 fibroblasts) by MTT assay. The results indicate that four ( BDHMFI , BDHFN , BMHMFI and BMHFN ) are inactive and the other four ( BDHFI , BDHAI , BMHFI and BMHAI ) show severe toxicities against human A549 and mouse 4T₁ cells, similar to the standard cisplatin. All the compounds exhibited weaker cytotoxicity against normal cells than cancer cells. The Swiss Target Prediction web server was applied for the prediction of protein targets. After analyzing the differences in frequency hits between these active and inactive Schiff bases, 18 probable targets were selected for reverse docking with the Surflex‐dock function in SYBYL‐X 2.0 software. Three target proteins, i.e. human ether‐á‐go‐go‐related (hERG) potassium channel, the inhibitor of apoptosis protein 3 and serine/threonine‐protein kinase PIM1, were chosen as the targets. Finally, the ligand‐based structure–activity relationships were analyzed based on the putative protein target (hERG) docking results, which will be used to design and synthesize novel hERG ion channel inhibitors.     

Two androsterone derivatives as inhibitors of androgen biosynthesis

The title compounds, (3R,5S,5′R,8R,9S,10S,13S,14S)‐10,13‐dimethyl‐5′‐(2‐methylpropyl)tetradecahydro‐6′H‐spiro[cyclopenta[a]phenanthrene‐3,2′‐[1,4]oxazinane]‐6′,17(2H)‐dione, C₂₆H₄₁NO₃, (I), and methyl (2R)‐2‐[(3R,5S,8R,9S,10S,13S,14S)‐10,13‐dimethyl‐2′,17‐dioxohexadecahydro‐3′H‐spiro[cyclopenta[a]phenanthrene‐3,5′‐[1,3]oxazolidin‐3′‐yl]]‐4‐methylpentanoate, C₂₈H₄₃NO₅, (II), possess the typical steroid shape (A–D rings), but they differ in their extra E ring. The azalactone E ring in (I) shows a half‐chair conformation, while the carbamate E ring of (II) is planar. The orientation of the E‐ring substituent is clearly established and allows a rationalization of the biological results obtained with such androsterone derivatives.     

In situ synthesis of mononuclear copper(II) complexes of the new tridentate ligand bis[(3,5‐dimethyl‐1H‐pyrazol‐1‐yl)methyl]amine

Two mononuclear copper complexes, {bis[(3,5‐dimethyl‐1H‐pyrazol‐1‐yl‐κN²)methyl]amine‐κN}(3,5‐dimethyl‐1H‐pyrazole‐κN²)(perchlorato‐κO)copper(II) perchlorate, [Cu(ClO₄)(C₅H₈N₂)(C₁₂H₁₉N₅)]ClO₄, (I), and {bis[(3,5‐dimethyl‐1H‐pyrazol‐1‐yl‐κN²)methyl]amine‐κN}bis(3,5‐dimethyl‐1H‐pyrazole‐κN²)copper(II) bis(hexafluoridophosphate), [Cu(C₅H₈N₂)₂(C₁₂H₁₉N₅)](PF₆)₂, (II), have been synthesized by the reactions of different copper salts with the tripodal ligand tris[(3,5‐dimethyl‐1H‐pyrazol‐1‐yl)methyl]amine (TDPA) in acetone–water solutions at room temperature. Single‐crystal X‐ray diffraction analysis revealed that they contain the new tridentate ligand bis[(3,5‐dimethyl‐1H‐pyrazol‐1‐yl)methyl]amine (BDPA), which cannot be obtained by normal organic reactions and has thus been captured in the solid state by in situ synthesis. The coordination of the Cu^II ion is distorted square pyramidal in (I) and distorted trigonal bipyramidal in (II). The new in situ generated tridentate BDPA ligand can act as a meridional or facial ligand during the process of coordination. The crystal structures of these two compounds are stabilized by classical hydrogen bonding as well as intricate nonclassical hydrogen‐bond interactions.     

Structural and spectroscopic characterization of two new blue luminescent pyridylbenzimidazole zinc(II) complexes

Luminescent metal complexes are used in photooptical devices. Zinc(II) complexes are of interest because of the ability to tune their color, their high thermal stability and their favorable carrier transport character. In particular, some zinc(II) complexes with aryl diimine and/or heterocyclic ligands have been shown to emit brightly in the blue region of the spectrum. Zinc(II) complexes bearing derivatized imidazoles have been explored for possible optoelectronic applications. The structures of two zinc(II) complexes of 5,6‐dimethyl‐2‐(pyridin‐2‐yl)‐1‐[(pyridin‐2‐yl)methyl]‐1H‐benzimidazole (L), namely dichlorido(dimethylformamide‐κO){5,6‐dimethyl‐2‐(pyridin‐2‐yl‐κN)‐1‐[(pyridin‐2‐yl)methyl]‐1H‐benzimidazole‐κN³}zinc(II) dimethylformamide monosolvate, [ZnCl₂(C₂₀H₁₈N₄)(C₃H₇NO)]·C₃H₇NO, (I), and bis(acetato‐κ²O,O′){5,6‐dimethyl‐2‐(pyridin‐2‐yl‐κN)‐1‐[(pyridin‐2‐yl)methyl]‐1H‐benzimidazole‐κN³}zinc(II) ethanol monosolvate, [Zn(C₂H₃O₂)₂(C₂₀H₁₈N₄)]·C₂H₅OH, (II), are reported. Complex (I) crystallized as a dimethylformamide solvate and exhibits a distorted trigonal bipyramidal coordination geometry. The coordination sphere consists of a bidentate L ligand spanning axial to equatorial sites, two chloride ligands in equatorial sites, and an O‐bound dimethylformamide ligand in the remaining axial site. The other complex, (II), crystallized as an ethanol solvate. The Zn^II atom has a distorted trigonal prismatic coordination geometry, with two bidentate acetate ligands occupying two edges and a bidentate L ligand occupying the third edge of the prism. Complexes (I) and (II) emit in the blue region of the spectrum. The results of density functional theory (DFT) calculations suggest that the luminescence of L results from π*←π transitions and that the luminescence of the complexes results from interligand charge‐transfer transitions. The orientation of the 2‐(pyridin‐2‐yl) substituent with respect to the benzimidazole system was found to have an impact on the calculated HOMO–LUMO gap (HOMO is highest occupied molecular orbital and LUMO is lowest unoccupied molecular orbital).     

(Z)‐3‐(1H‐Indol‐3‐yl)‐2‐(3‐thienyl)­acrylo­nitrile and (Z)‐3‐[1‐(4‐tert‐butyl­benzyl)‐1H‐indol‐3‐yl]‐2‐(3‐thienyl)­acrylo­nitrile

(Z)‐3‐(1H‐Indol‐3‐yl)‐2‐(3‐thienyl)­acrylo­nitrile, C₁₅H₁₀N₂S, (I), and (Z)‐3‐[1‐(4‐tert‐butyl­benzyl)‐1H‐indol‐3‐yl]‐2‐(3‐thienyl)­acrylo­nitrile, C₂₆H₂₄N₂S, (II), were prepared by base‐catalyzed reactions of the corresponding indole‐3‐carbox­aldehyde with thio­phene‐3‐aceto­nitrile. ¹H/¹³C NMR spectral data and X‐ray crystal structures of compounds (I) and (II) are presented. The olefinic bond connecting the indole and thio­phene moieties has Z geometry in both cases, and the mol­ecules crystallize in space groups P2₁/c and C2/c for (I) and (II), respectively. Slight thienyl ring‐flip disorder (ca 5.6%) was observed and modeled for (I).     

The 1:1 inclusion compounds zolmitriptan–benzene and zolmitriptan–phenol

In the benzene and phenol solvates of (S)‐4‐{3‐[2‐(dimethylamino)ethyl]‐1H‐indol‐5‐ylmethyl}oxazolidin‐2‐one, viz. C₁₆H₂₁N₃O₂·C₆H₆, (I), and C₁₆H₂₁N₃O₂·C₆H₅OH, (II), the host molecule has three linked residues, namely a planar indole ring system, an ethylamine side chain and an oxazolidinone system. It has comparable features to that of sumatriptan, although the side‐chain orientations of (I) and (II) differ from those of sumatriptan. Both (I) and (II) have host–guest‐type structures. The host molecule in (I) and (II) has an L‐shaped form, with the oxazolidinone ring occupying the base and the remainder of the molecule forming the upright section. In (I), each benzene guest molecule is surrounded by four host molecules, and these molecules are linked by a combination of N—H...N, N—H...O and C—H...O hydrogen bonds into chains of edge‐fused R₄⁴(33) rings. In (II), two independent molecules are present in the asymmetric unit, with similar conformations. The heterocyclic components are connected through N—H...N, N—H...O and C—H...O interactions to form chains of edge‐fused R₆⁴(38) rings, from which the phenol guest molecules are pendent, linked by O—H...O hydrogen bonds. The structures are further stabilized by extensive C—H...π interactions.     

Design,synthesis and crystallographic study of novel indole‐based cyano derivatives as key building blocks for heteropolycyclic compounds of major complexity

A four‐stage reaction sequence has been designed and developed for the synthesis of highly functionalized enolate esters as key building blocks for the synthesis of novel heteropolycyclic compounds of potential pharmaceutical value. The sequence starts with simple commercially available indoles and proceeds via 3‐(indol‐3‐yl)‐3‐oxopropanenitriles, which react with 2‐bromobenzaldehyde to form the corresponding chalcones; these are readily reduced to dihydrochalcones, which are in turn acylated to form the enolate esters. The compounds in this sequence have been characterized by IR and ¹H and ¹³C NMR spectroscopy, by mass spectrometry and by elemental analysis. The molecular and supramolecular structures are reported for representative examples, namely (E )‐3‐(2‐bromophenyl)‐2‐(1‐methyl‐1H‐indole‐3‐carbonyl)acrylonitrile, C₁₉H₁₃BrN₂O, (Ib ), (2RS )‐2‐(2‐bromobenzyl)‐3‐(1‐methyl‐1H‐indol‐3‐yl)‐3‐oxopropanenitrile, C₁₉H₁₅BrN₂O, (IIb ), and (2RS )‐3‐(1‐benzyl‐1H‐indol‐3‐yl)‐2‐(2‐bromobenzyl)‐3‐oxopropanenitrile, C₂₅H₁₉BrN₂O, (IIc ), the latter two of which crystallize with Z ′ = 2, and (E )‐1‐(1‐acetyl‐1H‐indol‐3‐yl)‐3‐(2‐bromophenyl)‐2‐cyanoprop‐1‐en‐1‐yl acetate, C₂₂H₁₇BrN₂O, (III), and (E )‐1‐(1‐benzyl‐1H‐indol‐3‐yl)‐3‐(2‐bromophenyl)‐2‐cyanoprop‐1‐en‐1‐yl benzoate, C₃₂H₂₃BrN₂O, (IV). The structure of the related chalcone (E )‐2‐benzoyl‐3‐(2‐bromophenyl)prop‐2‐enenitrile, (V), has been redetermined at 100 K, where it is monoclinic, as opposed to the triclinic form reported at ambient temperature.     

(S,S)‐Lactoyllactic acid and (S,S,S)‐lactoyllactoyllactic acid

The dimeric condensation product of lactic acid, namely (S,S)‐2‐[(2‐hydroxypropanoyl)oxy]propanoic acid, C₆H₁₀O₅, (I), crystallizes with two independent molecules in the asymmetric unit, which both have an essentially planar backbone. The trimeric condensation product, namely (S,S,S)‐3‐hydroxybut‐3‐en‐2‐yl 2‐[(2‐hydroxypropanoyl)oxy]propanoate, C₉H₁₄O₇, (II), has one molecule in the asymmetric unit and consists of two essentially planar parts, with the central C—O bond in a gauche conformation. Both molecules of the dimer are involved in intermolecular hydrogen bonds, forming chains with a C(8) graph set. These chains are connected by D(2) hydrogen bonds to form a two‐dimensional layer. The trimer forms hydrogen‐bonded C(10) and C₂²(6) chains, which together result in a two‐dimensional motif. The Hooft method [Hooft, Straver & Spek (2008). J. Appl. Cryst. 41 , 96–103] was successfully applied to the determination of the absolute structure of (I).     

Two novel organic–inorganic hybrid materials from tetrachloridometallate(II) salts and 4‐[(E)‐2‐(pyridin‐1‐ium‐2‐yl)ethenyl]pyridinium

Two organic–inorganic hybrid compounds have been prepared by the combination of the 4‐[(E)‐2‐(pyridin‐1‐ium‐2‐yl)ethenyl]pyridinium cation with perhalometallate anions to give 4‐[(E)‐2‐(pyridin‐1‐ium‐2‐yl)ethenyl]pyridinium tetrachloridocobaltate(II), (C₁₂H₁₂N₂)[CoCl₄], (I), and 4‐[(E)‐2‐(pyridin‐1‐ium‐2‐yl)ethenyl]pyridinium tetrachloridozincate(II), (C₁₂H₁₂N₂)[ZnCl₄], (II). The compounds have been structurally characterized by single‐crystal X‐ray diffraction analysis, showing the formation of a three‐dimensional network through X—H...Cl_nM⁻ (X = C, N⁺; n = 1, 2; M = Co^II, Zn^II) hydrogen‐bonding interactions and π–π stacking interactions. The title compounds were also characterized by FT–IR spectroscopy and thermogravimetric analysis (TGA).     

Syntheses and structures of three macrocyclic supramolecular complexes and one ZnII‐containing coordination polymer generated from a semi‐rigid multidentate N‐containing ligand

Semirigid organic ligands can adopt different conformations to construct coordination polymers with more diverse structures when compared to those constructed from rigid ligands. A new asymmetric semirigid organic ligand, 4‐{2‐[(pyridin‐3‐yl)methyl]‐2H‐tetrazol‐5‐yl}pyridine ( L ), has been prepared and used to synthesize three bimetallic macrocyclic complexes and one coordination polymer, namely, bis(μ‐4‐{2‐[(pyridin‐3‐yl)methyl]‐2H‐tetrazol‐5‐yl}pyridine)bis[dichloridozinc(II)] dichloromethane disolvate, [Zn₂Cl₄(C₁₂H₁₀N₆)₂]·2CH₂Cl₂, ( I ), the analogous chloroform monosolvate, [Zn₂Cl₄(C₁₂H₁₀N₆)₂]·CHCl₃, ( II ), bis(μ‐4‐{2‐[(pyridin‐3‐yl)methyl]‐2H‐tetrazol‐5‐yl}pyridine)bis[diiodidozinc(II)] dichloromethane disolvate, [Zn₂I₄(C₁₂H₁₀N₆)₂]·2CH₂Cl₂, ( III ), and catena‐poly[[[diiodidozinc(II)]‐μ‐4‐{2‐[(pyridin‐3‐yl)methyl]‐2H‐tetrazol‐5‐yl}pyridine] chloroform monosolvate], {[ZnI₂(C₁₂H₁₀N₆)]·CHCl₃}_n, ( IV ), by solution reaction with ZnX₂ (X = Cl and I) in a CH₂Cl₂/CH₃OH or CHCl₃/CH₃OH mixed solvent system at room temperature. Complex ( I ) is isomorphic with complex ( III ) and has a bimetallic ring possessing similar coordination environments for both of the Zn^II cations. Although complex ( II ) also contains a bimetallic ring, the two Zn^II cations have different coordination environments. Under the influence of the I^? anion and guest CHCl₃ molecule, complex ( IV ) displays a significantly different structure with respect to complexes ( I )–( III ). C—H…Cl and C—H…N hydrogen bonds, and π–π stacking or C—Cl…π interactions exist in complexes ( I )–( IV ), and these weak interactions play an important role in the three‐dimensional structures of ( I )–( IV ) in the solid state. In addition, the fluorescence properties of L and complexes ( I )–( IV ) were investigated.     

Understanding the microcrystal tests of three related phenethylamines: the ortho‐metallated (±)‐amphetamine formed with gold(III) chloride,and the tetrachloridoaurate(III) salts of (+)‐methamphetamine and (±)‐ephedrine

The ortho‐metallation product of the reaction of (±)‐amphetamine with gold(III) chloride, [D,L‐2‐(2‐aminopropyl)phenyl‐κ²N,C¹]dichloridogold(III), [Au(C₉H₁₂N)Cl₂], and the two salts resulting from crystallization of (+)‐methamphetamine with gold(III) chloride, D‐methyl(1‐phenylpropan‐2‐yl)azanium tetrachloridoaurate(III), (C₁₀H₁₆N)[AuCl₄], and of (±)‐ephedrine with gold(III) chloride, D,L‐(1‐hydroxy‐1‐phenylpropan‐2‐yl)(methyl)azanium tetrachloridoaurate(III), (C₁₀H₁₆NO)[AuCl₄], have different structures. The first makes a bidentate complex directly with a dichloridogold(III) group, forming a six‐membered ring structure; the second and third each form a salt with [AuCl₄]⁻ (each has two formula units in the asymmetric unit). The organic components are all members of the same class of stimulants that are prevalent in illicit drug use. These structures are important contributions to the understanding of the microcrystal tests for these drugs that have been employed for well over 100 years.     

Structural studies of (prop‐2‐en‐1‐yl)bis[(pyridin‐2‐yl)methylidene]amine hetero‐scorpionate copper complexes

The structures of five compounds consisting of (prop‐2‐en‐1‐yl)bis[(pyridin‐2‐yl)methylidene]amine complexed with copper in both the Cu^I and Cu^II oxidation states are presented, namely chlorido{(prop‐2‐en‐1‐yl)bis[(pyridin‐2‐yl)methylidene]amine‐κ³N,N′,N′′}copper(I) 0.18‐hydrate, [CuCl(C₁₅H₁₇N₃)]·0.18H₂O, (1), catena‐poly[[copper(I)‐μ₂‐(prop‐2‐en‐1‐yl)bis[(pyridin‐2‐yl)methylidene]amine‐κ⁵N,N′,N′′:C²,C³] perchlorate acetonitrile monosolvate], {[Cu(C₁₅H₁₇N₃)]ClO₄·CH₃CN}_n, (2), dichlorido{(prop‐2‐en‐1‐yl)bis[(pyridin‐2‐yl)methylidene]amine‐κ³N,N′,N′′}copper(II) dichloromethane monosolvate, [CuCl₂(C₁₅H₁₇N₃)]·CH₂Cl₂, (3), chlorido{(prop‐2‐en‐1‐yl)bis[(pyridin‐2‐yl)methylidene]amine‐κ³N,N′,N′′}copper(II) perchlorate, [CuCl(C₁₅H₁₇N₃)]ClO₄, (4), and di‐μ‐chlorido‐bis({(prop‐2‐en‐1‐yl)bis[(pyridin‐2‐yl)methylidene]amine‐κ³N,N′,N′′}copper(II)) bis(tetraphenylborate), [Cu₂Cl₂(C₁₅H₁₇N₃)₂][(C₆H₅)₄B]₂, (5). Systematic variation of the anion from a coordinating chloride to a noncoordinating perchlorate for two Cu^I complexes results in either a discrete molecular species, as in (1), or a one‐dimensional chain structure, as in (2). In complex (1), there are two crystallographically independent molecules in the asymmetric unit. Complex (2) consists of the Cu^I atom coordinated by the amine and pyridyl N atoms of one ligand and by the vinyl moiety of another unit related by the crystallographic screw axis, yielding a one‐dimensional chain parallel to the crystallographic b axis. Three complexes with Cu^II show that varying the anion composition from two chlorides, to a chloride and a perchlorate to a chloride and a tetraphenylborate results in discrete molecular species, as in (3) and (4), or a bridged bis‐μ‐chlorido complex, as in (5). Complex (3) shows two strongly bound Cl atoms, while complex (4) has one strongly bound Cl atom and a weaker coordination by one perchlorate O atom. The large noncoordinating tetraphenylborate anion in complex (5) results in the core‐bridged Cu₂Cl₂ moiety.     

Three‐dimensional hydrogen‐bonded framework structures in flunarizinium nicotinate and flunarizinediium bis(4‐toluenesulfonate) dihydrate

The structures of two salts of flunarizine, namely 1‐bis[(4‐fluorophenyl)methyl]‐4‐[(2E)‐3‐phenylprop‐2‐en‐1‐yl]piperazine, C₂₆H₂₆F₂N₂, are reported. In flunarizinium nicotinate {systematic name: 4‐bis[(4‐fluorophenyl)methyl]‐1‐[(2E)‐3‐phenylprop‐2‐en‐1‐yl]piperazin‐1‐ium pyridine‐3‐carboxylate}, C₂₆H₂₇F₂N₂⁺·C₆H₄NO₂⁻, (I), the two ionic components are linked by a short charge‐assisted N—H...O hydrogen bond. The ion pairs are linked into a three‐dimensional framework structure by three independent C—H...O hydrogen bonds, augmented by C—H...π(arene) hydrogen bonds and an aromatic π–π stacking interaction. In flunarizinediium bis(4‐toluenesulfonate) dihydrate {systematic name: 1‐[bis(4‐fluorophenyl)methyl]‐4‐[(2E)‐3‐phenylprop‐2‐en‐1‐yl]piperazine‐1,4‐diium bis(4‐methylbenzenesulfonate) dihydrate}, C₂₆H₂₈F₂N₂²⁺·2C₇H₇O₃S⁻·2H₂O, (II), one of the anions is disordered over two sites with occupancies of 0.832 (6) and 0.168 (6). The five independent components are linked into ribbons by two independent N—H...O hydrogen bonds and four independent O—H...O hydrogen bonds, and these ribbons are linked to form a three‐dimensional framework by two independent C—H...O hydrogen bonds, but C—H...π(arene) hydrogen bonds and aromatic π–π stacking interactions are absent from the structure of (II). Comparisons are made with some related structures.     

Supramolecular motifs in the first structures of organic carboxylate salts of 1‐(diaminomethylene)thiourea (HATU)

The structures of the first two organic carboxylate salts of 1‐(diaminomethylene)thiourea (HATU), namely 1‐(diaminomethylene)thiouron‐1‐ium formate, C₂H₇N₄S⁺·HCOO⁻, (I), and bis[1‐(diaminomethylene)thiouron‐1‐ium] oxalate dihydrate, 2C₂H₇N₄S⁺·C₂O₄²⁻·2H₂O, (II), in which the oxalate lies on a symmetry centre, possess different extended hydrogen‐bonding networks with different graph‐set motifs. The R₂²(8) motif present in (I) does not appear in (II), but an R₂¹(6) motif is present in both (I) and (II). Compound (I) has a three‐dimensional hydrogen‐bonding network, whereas (II) has a layered structure with layers joined by hydrogen‐bonding motifs that form R₄²(8) patterns. This work extends the known supramolecular structural data for HATU to include these organic carboxylates in addition to the previously characterized salts with inorganic acids.     

Two one‐dimensional coordination polymers generated from a new benzimidazole bridging ligand and CdX2 (X = Br and I)

The novel asymmetric bridging ligand 1‐[(pyridin‐3‐yl)methyl]‐2‐[4‐(pyridin‐3‐yl)phenyl]‐1H‐benzimidazole (L) has been used to construct the coordination polymers catena‐poly[[[dibromidocadmium(II)]‐μ₃‐1‐[(pyridin‐3‐yl)methyl]‐2‐[4‐(pyridin‐3‐yl)phenyl]‐1H‐benzimidazole] monohydrate], {[CdBr₂(C₂₄H₁₈N₄)]·H₂O}_n, (I), and catena‐poly[[diiodidocadmium(II)]‐μ₃‐1‐[(pyridin‐3‐yl)methyl]‐2‐[4‐(pyridin‐3‐yl)phenyl]‐1H‐benzimidazole], [CdI₂(C₂₄H₁₈N₄)]_n, (II). Compounds (I) and (II) are closely related one‐dimensional polymers based on 16‐ and 20‐membered macrocycles along the chains, but they are not isomorphous. The chains are crosslinked into a two‐dimensional network via hydrogen bonds and π–π interactions in (I), and into a three‐dimensional framework through π–π interactions in (II). One well‐ordered solvent water molecule per asymmetric unit is included in (I) and forms O...Br hydrogen bonds.